Skip to content

To see the effect of Nalikeranjana and Kachyapananjana with Triphala Kwath orally in Kacha (Immature Senile Cataract)

Comparative Clinical Evaluation of Nalikeranjana and Kachyapananjana with Triphala Kwath orally in Kacha (Immature Senile Cataract) - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054990
Enrollment
60
Registered
2023-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H258- Other age-related cataract

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having specific sign and symptoms of Kacha (Immature Senile Cataract). 2.Patient between 45-75 years of age. 3.Patient having best corrected visual acuity not less than Log MAR 1.0 4.Patient willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Mature and Hyper Mature Cataract and Nuclear Cataract more than grade III lens opacity as per LOCS III Criteria. 2.Congenital, Developmental, Traumatic, complicated cataract. 3.Any other ocular pathology that can cause diminution of vision like Diabetic Retinopathy, Macular Degeneration, Macular Degeneration, Retinitis Pigmentosa, Pathological Myopia, Uveitis. 4.Patient underwent any surgical intervention to eye. 5. Patient undergoing treatment for any other serious systemic illness. 6. Patient having uncontrolled Diabetes Mellitus, Hypertension. 7. Patient who are already registered under some other serious ongoing medical research.

Design outcomes

Primary

MeasureTime frame
Blurred visionTimepoint: 0,8 weeks,10 weeks, 12 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactRitu

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

drpreeti25@gmail.com9953117417

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026